IP Library Granted Patent US 7,408,058
Granted Patent B2
US 7,408,058 · App. 10/760,968 · Granted Aug 5, 2008

Regioisomerically pure oxochlorins and methods of synthesis

Assignee: North Carolina State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,408,058
App. No.
10/760,968
Granted
Aug 5, 2008
Kind
B2
Abstract

A method of making an oxochlorin comprises the steps of oxidizing a chlorin to produce a mixture of hydronchlorin and oxochlorin, and then oxidizing the hydroxychlorin in said mixture, preferably with DDQ, to produce a mixture consisting essentially of oxochlorin. The step of oxidizing a chlorin is carried out by exposing the chlorin to alumina, typically in the presence of an oxidizing agent such as air or alumina. The oxidizing steps may be carried out in an organic solvent such as toluene. The chlorin is preferably a C-methylated chlorin, and is preferably metalated.

Claims (39)

1. A trans substituted oxochlorin compound of Formula X:

wherein:

M is a metal selected from the group consisting of Zn, Mg, Pt, Pd, Sn and Al;

K 1 , K 2 , K 3 , and K 4 are independently selected from the group consisting of N, O, S, Se, Te, and CH;

S 1 , S 2 , S 3 , S 4 , S 5 , S 6 , S 8 , S 9 , S 10 , S 11 , S 12 , and S 14 are independently selected from the group consisting of H, aryl, phenyl, alkyl, cycloalkyl, spiroalkyl, alkenyl, alkynyl, halogen, alkoxy, alkylthio, perfluoroalkyl, perfluoroaryl, pyridyl, cyano, thiocyanato, nitro, amino, alkylamino, acyl, sulfoxyl, sulfonyl, imido, amido, and carbamoyl;

wherein S 7 and S 13 are together ═O;

and wherein either (i) S 1 and S 5 are trans-substituted linking groups Q 1 and Q 2 , (ii) S 2 and S 6 are trans-substituted linking groups Q 1 and Q 2 , (iii) S 10 and S 12 are trans-substituted linking groups Q 1 and Q 2 , or (iv) S 9 and S 11 are trans-substituted linking groups Q 1 and Q 2 ; and

Q 1 and Q 2 are independently selected linking groups of the formula:

wherein:

n is from 0 or 1 to 5 or 10;

R 3 may be present or absent;

R 1 , R 2 , and R 3 are each independently selected from the group consisting of ethene, ethyne, aryl, and heteroaryl groups, which aryl and heteroaryl groups may be unsubstituted or substituted one or more times with H, aryl, phenyl, cycloalkyl, alkyl, alkenyl, alkynyl, halogen, alkoxy, alkylthio, perfluoroalkyl, perfluoroaryl, pyridyl, cyano, thiocyanato, nitro, amino, alkylamino, acyl, sulfoxyl, sulfonyl, imido, amido, and carbamoyl; and

Y is a protected or unprotected reactive substituent selected from the group consisting of hydroxy, thio, seleno, telluro, ester, carboxylic acid, boronic acid, phenol, silane, sulfonic acid, phosphonic acid, alkylthiol, formyl, halo, alkenyl, alkynyl, haloalkyl, dialkyl phosphonate, alkyl sulfonate, acetylacetone, and dialkyl boronate groups.

2. The compound according to claim 1 , wherein S 9 and S 11 are trans-substituted linking groups Q 1 and Q 2 .

3. The compound according to claim 1 , wherein S 10 and S 12 are trans-substituted lining groups Q 1 and Q 2 .

4. The compound according to claim 1 , wherein neither S 8 nor S 14 is H.

5. The compound according to claim 1 , wherein M is Zn or Mg.

6. The compound according to claim 1 , wherein K 1 , K 2 , K 3 , and K 4 are independently selected from the group consisting of N, O, S, and CH.

7. The compound according to claim 1 , wherein K 1 , K 2 , K 3 , and K 4 are all N.

8. The compound according to claim 1 , wherein S 4 , S 7 , S 8 , S 9 , S 10 , S 11 , S 12 , and S 14 are all alkyl.

9. The compound according to claim 1 , wherein K 1 , K 2 , K 3 , and K 4 are independently selected from the group consisting of N, O, S, and CH.

10. The compound according to claim 1 , wherein K 1 , K 2 , K 3 , and K 4 are all N.

11. The compound according to claim 1 , wherein S 4 , S 8 , and S 14 are all alkyl.

12. A trans substituted oxochlorin compound of Formula X:

wherein:

M is absent;

K 1 , K 2 , K 3 , and K 4 are independently selected from the group consisting of N, 0, 5, Se, Te, and CH;

S 1 , S 2 , S 3 S 4 , S 5 , S 6 , S 8 , S 9 , S 10 , S 11 , S 12 , and S 14 are independently selected from the group consisting of H, aryl, alkyl, cycloalkyl, spiroalkyl, alkenyl, alkynyl, halogen, alkoxy, alkylthio, perfluoroalkyl, periluoroaryl, pyridyl, cyano, thiocyanato, nitro, amino, alkylamino, acyl, sulfoxyl, sulfonyl, imido, amido, and carbamoyl;

wherein S 7 and S 13 are together ═O;

and wherein either (i) S 10 and S 12 are trans-substituted linking groups Q 1 and Q 2 , or S 9 and S 11 are trans-substituted linking groups Q 1 and Q 2 ; and

Q 1 and Q 2 are independently selected linking groups of the formula:

wherein:

n is from 0 or 1 to 5 or 10;

R 3 may be present or absent;

R 1 , R 2 , and R 3 are each independently selected from the group consisting of ethene, ethyne, aryl, and heteroaryl groups, which aryl and heteroaryl groups may be unsubstituted or substituted one or more times with H, aryl, phenyl, cycloalkyl, alkyl, alkenyl, alkynyl, halogen, alkoxy, alkylthio, perfluoroalkyl, perfluoroaryl, pyridyl, cyano, thiocyanato, nitro, amino, alkylamino, acyl, sulfoxyl, sulfonyl, imido, amido, and carbamoyl; and

Y is a protected or unprotected reactive substituent selected from the group consisting of hydroxy, thio, seleno, telluro, ester, carboxylic acid, boronic acid, phenol, silane, sulfonic acid, phosphonic acid, alkyithiol, formyl, halo, alkenyl, alkynyl, haloalkyl, dialkyl phosphonate, alkyl sulfonate, acetylacetone, and dialkyl boronate groups.

13. The compound according to claim 12 , wherein S 9 and S 11 are trans-substituted linking groups Q 1 and Q 2 .

14. The compound according to claim 12 , wherein S 10 and 12 are trans-substituted linking groups Q 1 and Q 2 .

15. The compound according to claim 12 , wherein neither S 8 nor S 14 is H.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 30, 2017
From: NORTH CAROLINA STATE UNIVERSITY RALEIGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043070/0798 →
Continuity (5)
Division 1001112100 · Dec 7, 2001
Continuation In Part 0985256000 · May 10, 2001
Continuation In Part 0967046300 · Sep 26, 2000
Continuation In Part 0962179700 · Jul 21, 2000
Related Publication 20040152887A1 · Aug 5, 2004